Over the past decade, significant decreases in adverse event rates have been observed for #CV conditions such as AMI and HF. Biome is committed to partnering with #healthsystems across the country to improve patient outcomes and maximize #patientsafety. jamanetwork.com/journals/jama/…

30-day Readmission rates post #TAVR remain steady throughout all volume hospitals. Biome #Analytics can track your rates amongst others. #Cardiology ahajournals.org/doi/10.1161/JA…

A healthy lifestyle has many benefits, but sleep is one of the most important; following sleep recommendations can significantly reduce the risk for #cardiovascular disease. To read more check out the article published in the AJPM last month! sciencedirect.com/science/articl…

Emerging #AI technology can predict risk factors for #CV patients and potential surgical outcomes. Biome couples #machinelearning with deep #CV subject matter expertise to surface areas for quality improvement in your program. ncbi.nlm.nih.gov/pmc/articles/P…

Supporting research to understand the relationship between #coronaryarterydisease and outcomes in structural heart intervention is part of the critical work we do every day at Biome. Learn more at biome.io #Cardiology #Hospital #healthdata jacc.org/doi/full/10.10…

Biome partners with leading national #healthcare systems to provide #analytics and insights into key performance measures such as discharge medication compliance. Our goal is simple, better care, more patients, and lower cost. Biome.io

The FDA market clearance for the Edwards Pascal device marks the second dedicated #transcatheter mitral valve repair device approved in the US. We are proud to partner with #healthsystems across the country analyzing outcomes for patients with degenerative mitral regurgitation.

Heart failure expenditures are growing faster than many other chronic conditions. Granular #analyses in this population cohort are needed to improve outcomes and maximize value. Learn more about how Biome is supporting this call to action at biome.io #Cardiology

Each year, the @ucsfhealthaward recognizes innovative technologies in #digitalhealth. We're thrilled to announce our application to the Rising Star track! Winners announced at HLTH Conference in Las Vegas, November 14. Info to support the Awards: bit.ly/3dGPL3o. #DHA2022

Hospitals across the country are working to decrease the incidence of stroke after #TAVR. The results of the PROTECTED TAVR trial found that while CEP did not significantly affect the incidence of periprocedural stroke, the result may not rule out the benefits of CEP during TAVR.

Our Performance Manager™ aggregates health system data, aligns care teams around clinically relevant performance measures, and empowers them to accelerate clinical and financial improvement. businesswire.com/news/home/2022…

.Biome announced the release of the Biome Performance Manager, a next-generation application to help hospitals and care teams accelerate clinical and financial improvement and manage more improvement initiatives with fewer resources. ow.ly/cqyR50L0fen

Preventing CI-AKI is at the top of my mind for care teams across the country. At Biome, we are committed to supporting #clinicians in improving outcomes and safety. Learn more about our work to reduce CI-AKI at Biome.io

We have some great news to share. It’s with pleasure that we announce Stephen Hiscott as Biome Analytics' new CRO. “I’m honored and excited to join Biome at a pivotal time in the company’s growth.” businesswire.com/news/home/2022…

Predictors of readmission after #TEER in patients with baseline and new onset #AFib (NOAF) were studied using the nationwide readmissions database and concluded that those with NOAF experienced longer index admissions and had more co-morbidities. sciencedirect.com/science/articl…!

16 StartUp Health portfolio companies are finalists for the UCSF Digital Health Awards hosted at HLTH 2022 in Las Vegas! Read up on the StartUp Health finalists and see what awards they're nominated for ⤵️ ow.ly/pXlR50LmW5o @ucsfhealthaward

The #ACC has published new guidance for the treatment of #patients with #ASCVD and other chronic conditions such as hypertension, diabetes, & #afib. The authors highlight the necessity of providers working as a team while treating patients with multiple comorbidities

Partnership in Action: #Barnes-Jewish Hospital & Biome Analytics deliver breakthrough #AKI prevention in #cardiovascular care. We achieved: -O/E Ratios: STEMI (0.87), NSTEMI (0.22) -$17K–$41K savings per patient -Precision care with innovative tools